The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
Subscribe To Our Newsletter & Stay Updated
